MARKET INSIGHTS
Biotin Market was valued at USD 850 million in 2024 and is projected to reach USD 1,420 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period (2025-2032). This growth trajectory reflects biotin’s expanding applications across nutraceuticals, cosmetics, and pharmaceuticals.
Biotin, classified as vitamin B7 or vitamin H, is a water‑soluble nutrient essential for metabolizing fats, carbohydrates, and proteins. Its ability to support healthy hair, skin, and nails has fueled widespread adoption in dietary supplements and personal care formulations. While naturally present in foods like eggs and nuts, synthetic biotin dominates commercial production due to cost efficiency and standardized potency.
Three primary drivers are accelerating market expansion: rising disposable incomes in emerging economies, growing demand for beauty‑from‑within supplements, and increased veterinary applications for livestock nutrition. However, stringent regulatory frameworks in North America and Europe continue to shape product development strategies. Major players like DSM, BASF, and Zhejiang Medicine are investing in bioavailability enhancement technologies, responding to consumer demand for premium nutraceutical solutions with higher efficacy.
Biotin Market – View in Detailed Research Report
The global biotin market is projected to grow at a CAGR of 6.8% from 2025 to 2032, reaching USD 1,420 million by 2032. The market size in 2024 was USD 850 million, reflecting robust demand across nutraceuticals, cosmetics, and pharmaceuticals. The market is driven by increasing health consciousness, the rise of personalized nutrition, and expanding veterinary applications.
Biotin is a water‑soluble vitamin essential for cellular metabolism and is widely used to support healthy hair, skin, and nails. It is found naturally in foods such as eggs, nuts, and leafy greens, but most commercial biotin is produced synthetically to ensure consistent potency and cost efficiency.
Top 10 Companies in the Biotin Market (2026)
-
Zhejiang Medicine Co., Ltd.
Headquarters: Hangzhou, China
Key Offering: D‑Biotin, synthetic biotin, and biotin‑infused nutraceuticalsZhejiang Medicine is the largest global supplier of D‑biotin, accounting for roughly 30% of worldwide demand. The company’s vertically integrated production facilities enable cost leadership and rapid scale‑up to meet rising regional needs. Its focus on high‑purity, pharmaceutical‑grade biotin supports both supplement and drug development markets.
Sustainability & Growth Initiatives:
- Investment in green fermentation processes to reduce CO₂ emissions by 15%
- Strategic partnerships with Asian nutraceutical brands to expand distribution
- R&D for next‑generation bio‑available biotin analogs
-
DSM Nutritional Products
Headquarters: Heerlen, Netherlands
Key Offering: Premium biotin formulations, high‑purity D‑biotin, and biotin‑based pharmaceutical excipientsDSM leverages its extensive distribution network across Europe and North America to supply high‑quality biotin for dietary supplements, cosmetics, and clinical applications. The company’s focus on bioavailability enhancement has positioned it as a leader in nutraceutical innovation.
Sustainability & Growth Initiatives:
- Carbon‑neutral production targets by 2035
- Collaboration with research institutes on personalized nutrition solutions
- Expansion of online retail channels to capture e‑commerce growth
-
BASF SE
Headquarters: Ludwigshafen, Germany
Key Offering: Biotin derivatives for pharmaceutical and cosmetic applicationsBASF’s expertise in chemical synthesis enables the production of high‑purity biotin variants tailored for drug delivery and advanced skincare products. The company is actively investing in encapsulation technologies to improve bioavailability.
Sustainability & Growth Initiatives:
- Implementation of circular economy principles in biotin production
- Strategic alliances with cosmetic brands to develop green‑certified formulations
- Investment in digital platforms for supply chain transparency
-
CSPC Pharmaceutical Group
Headquarters: Shanghai, China
Key Offering: D‑biotin, veterinary biotin supplements, and feed additivesCSPC is a leading biotin manufacturer in Asia, with extensive capabilities in both pharmaceutical‑grade and animal nutrition biotin. The company’s focus on veterinary applications has opened a significant new revenue stream.
Sustainability & Growth Initiatives:
- Energy‑efficient fermentation plants reducing production costs by 12%
- Research into biotin‑based feed additives for improved livestock health
- Expansion into Southeast Asian markets through local production hubs
-
Hangzhou Sino Biotech Co., Ltd.
Headquarters: Hangzhou, China
Key Offering: Custom biotin blends for dietary supplements and cosmeticsHangzhou Sino Biotech has carved out a niche in competitive pricing and rapid product development. Its close relationships with supplement brands enable quick market entry for new biotin formulations.
Sustainability & Growth Initiatives:
- Adoption of eco‑friendly packaging solutions
- Collaboration with genomics companies for personalized nutrition
- Investment in advanced fermentation to boost yield
-
Ningbo Shenzhou Biotech Co., Ltd.
Headquarters: Ningbo, China
Key Offering: High‑purity D‑biotin and biotin‑infused nutraceuticalsShenzhou Biotech focuses on delivering premium biotin for both domestic and international markets. Its strong R&D pipeline includes biotin analogs with improved absorption.
Sustainability & Growth Initiatives:
- Implementation of renewable energy in manufacturing plants
- Partnerships with e‑commerce platforms for direct consumer sales
- Continuous improvement of product quality certifications (ISO, GMP)
-
Shanghai Xinfu Pharmaceutical Co.
Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade biotin and biotin‑based drug excipientsXinfu Pharmaceutical supplies biotin to the pharmaceutical sector, supporting drug formulation and clinical trials. The company’s focus on high purity and stringent quality controls differentiates it in the market.
Sustainability & Growth Initiatives:
- Development of low‑carbon manufacturing processes
- Expansion of R&D into biotin‑based therapeutic agents
- Collaboration with global pharma companies for co‑development projects
-
Hebei Huafeng Pharmaceutical Group
Headquarters: Shijiazhuang, China
Key Offering: D‑biotin, veterinary biotin, and biotin‑infused animal feedHuafeng focuses on biotin for animal nutrition, providing feed additives that improve eggshell quality and livestock health. Its competitive pricing has captured a growing share of the emerging markets.
Sustainability & Growth Initiatives:
- Adoption of waste‑to‑energy solutions in production
- Strategic alliances with regional feed manufacturers
- Investment in digital supply chain management
-
Zhejiang Shengda Bio‑Pharm Co.
Headquarters: Hangzhou, China
Key Offering: High‑purity D‑biotin for nutraceutical and pharmaceutical useShengda Bio‑Pharm delivers top‑grade biotin for both dietary supplements and clinical applications. Its focus on quality and regulatory compliance has positioned it as a trusted supplier in the global market.
Sustainability & Growth Initiatives:
- Implementation of ISO 14001 environmental management systems
- Collaboration with universities for biotin research
- Expansion of export channels to Europe and North America
-
CSPC Pharmaceutical Group (Asia‑Pacific Expansion)
Headquarters: Shanghai, China
Key Offering: D‑biotin for nutraceuticals and veterinary nutritionWith a strong foothold in the Asia‑Pacific region, CSPC continues to expand its biotin portfolio, targeting high‑growth markets such as India and Southeast Asia.
Sustainability & Growth Initiatives:
- Investment in local production facilities to reduce logistics costs
- Partnerships with regional research institutes for product innovation
- Commitment to carbon‑neutral operations by 2030
Biotin Market – View in Detailed Research Report
Outlook
The biotin market is expected to maintain steady growth, driven by rising health awareness, the expansion of nutraceuticals, and increased demand from the cosmetic and veterinary sectors. Regulatory tightening in North America and Europe will continue to shape product innovation, while emerging economies will offer the highest growth rates.
Future Trends
- Nutricosmetics: Growing consumer preference for ingestible beauty solutions will boost biotin‑infused product sales.
- Personalized Nutrition: DNA‑based vitamin plans are likely to increase biotin usage in customized formulations.
- Digital & E‑commerce Expansion: Online retail will become a dominant distribution channel, especially in the Asia‑Pacific region.
- Green Manufacturing: Companies investing in sustainable production methods will gain a competitive edge.
- Veterinary Applications: Biotin’s role in livestock health will drive demand in the animal nutrition segment.
- Top 10 Companies in the P‑Toluenesulfonyl Semicarbazide Market (2026): Market Leaders Driving Global Plastics Innovation - May 22, 2026
- Top 10 Companies in the Global Ceria Slurries Market (2026): Market Leaders Powering Innovation - May 22, 2026
- Top 10 Companies in the Global Hubless Dicing Blade Market (2026): Market Leaders Powering Precision Cutting - May 22, 2026
